EPS Holdings Inc. | Cash Flow

Fiscal year is October-September. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,437
4,252
4,542
6,758
8,034
7,228
Depreciation, Depletion & Amortization
639
781
821
1,306
1,860
1,979
Other Funds
80
88
114
117
102
3,393
Funds from Operations
1,726
4,012
4,303
4,039
6,578
5,813
Changes in Working Capital
1,085
419
117
1,147
1,257
2,348
Net Operating Cash Flow
641
4,431
4,186
5,186
7,835
3,465
Capital Expenditures
699
746
625
568
809
Sale of Fixed Assets & Businesses
25
-
-
-
59
Purchase/Sale of Investments
228
733
285
75
2,011
Net Investing Cash Flow
3,028
3,052
1,276
1,315
4,122
Cash Dividends Paid - Total
626
643
662
827
1,131
Issuance/Reduction of Debt, Net
2,555
436
592
920
1,100
Net Financing Cash Flow
1,849
625
83
2,515
2,401
Net Change in Cash
34
1,063
2,999
803
6,489
Free Cash Flow
103
3,992
3,709
4,743
7,206
Net Assets from Acquisitions
1,710
1,387
-
-
1,341
Other Sources
129
-
-
-
-
Change in Capital Stock
-
329
101
885
4,735
Exchange Rate Effect
504
308
172
553
375
Other Uses
545
186
366
670
17

About EPS Holdings

View Profile
Address
Kagurazaka AK Building, 6/F
Tokyo Tokyo 162
Japan
Employees -
Website http://www.eps-holdings.co.jp
Updated 07/08/2019
EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin and Others. The CRO segment offers clinical trials, data management, and statistical analysis.